19-53050203-C-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001191055.2(ERVV-2):āc.952C>Gā(p.Gln318Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001191055.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000672 AC: 1AN: 148708Hom.: 0 Cov.: 22
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000193 AC: 2AN: 1036860Hom.: 0 Cov.: 15 AF XY: 0.00000191 AC XY: 1AN XY: 523574
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000672 AC: 1AN: 148824Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 72510
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.952C>G (p.Q318E) alteration is located in exon 2 (coding exon 1) of the ERVV-2 gene. This alteration results from a C to G substitution at nucleotide position 952, causing the glutamine (Q) at amino acid position 318 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at